Poisoning Mortality for 2016-20 by County
This layer displays poisoning mortality rates from the CDC’s National Vital Statistics System – Mortality database. Data are 5-year aggregates for 2016-20 and grouped by ICD-10 codes.
This layer displays poisoning mortality rates from the CDC’s National Vital Statistics System – Mortality database. Data are 5-year aggregates for 2016-20 and grouped by ICD-10 codes.
This layer displays the locations of all addiction or substance abuse providers with a CMS National Provider Identifier (NPI). Addiction or substance abuse providers include MDs, DOs, and other credentialed professionals specializing substance abuse treatment, rehabilitation, addiction medicine, or providing … Continued
This layer displays opioid overdose mortality rates from the CDC’s National Vital Statistics System – Mortality database. Data are 5-year aggregates for 2016-20 and grouped by ICD-10 codes.
This layer contains the location of practitioners authorized to treat opioid dependency with buprenorphine in the latest report year (2023).
Layer displays the percentage of claims for prescription drugs among Medicare Part D beneficiaries that were for opioid drugs in 2018. Data is available by county, ZIP Code Tabulation Area (ZCTA) and by physician (address).
This layer contains the location of practitioners authorized to treat opioid dependency with buprenorphine in the latest report year (2022).
This layer displays opioid overdose mortality rates from the CDC’s National Vital Statistics System – Multiple Cause of Death database. Data are 5-year aggregates for 2014-18 and grouped by ICD-10 codes.
Layer displays the percentage of claims for prescription drugs among Medicare Part D beneficiaries that were for opioid drugs in 2018. Data is available by county, ZIP Code Tabulation Area (ZCTA) and by physician (address).
This layer displays the percentage of Medicare beneficiaries with opioid use disorder in the latest report year (2019).
Layer displays the 5-year rate of change in claims for prescription opioid drugs among Medicare Part D beneficiaries (as a percentage of all prescription drug claims). Data show the change between 2017 and 2021.